Daniel J. Starks, Director at ABBOTT LABORATORIES (ABT), bought 12,286 shares at $92.65 ($927K) on 2026-04-27, disclosed to the SEC on 2026-04-28.
Seasonal purchase ($927k) by Director — this insider has traded ABT in April in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,286 | $0 | 0.0% |
| 2 | $92.65 | 10,000 | $927K | 100.0% |
| Total | $75.41 avg | 12,286 | $927K | 100% |
| Filing → |
| ABT | SELL | 2023-07-28 | $11.4M | — | Filing → |
| ABT | SELL | 2023-05-02 | $10.7M | — | Filing → |
| ABT | SELL | 2022-10-31 | $9.7M | — | Filing → |